These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 30321532

  • 1. Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice.
    Srikanth M, Chew WS, Hind T, Lim SM, Hay NWJ, Lee JHM, Rivera R, Chun J, Ong WY, Herr DR.
    Eur J Pharmacol; 2018 Dec 15; 841():49-56. PubMed ID: 30321532
    [Abstract] [Full Text] [Related]

  • 2. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
    Murai N, Hiyama H, Kiso T, Sekizawa T, Watabiki T, Oka H, Aoki T.
    Neuropharmacology; 2017 Nov 15; 126():97-107. PubMed ID: 28859883
    [Abstract] [Full Text] [Related]

  • 3. Lysophosphatidic acid receptor1/3 antagonist inhibits the activation of satellite glial cells and reduces acute nociceptive responses.
    Hoshino Y, Okuno T, Saigusa D, Kano K, Yamamoto S, Shindou H, Aoki J, Uchida K, Yokomizo T, Ito N.
    FASEB J; 2022 Apr 15; 36(4):e22236. PubMed ID: 35218596
    [Abstract] [Full Text] [Related]

  • 4. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
    Uchida H, Nagai J, Ueda H.
    Mol Pain; 2014 Nov 19; 10():71. PubMed ID: 25411045
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY, Zhao EY, Zhuang WX, Sun FX, Han HL, Han HR, Lin ZJ, Pan ZF, Qu MH, Zeng XW, Ding Y.
    Neurol Sci; 2015 Nov 19; 36(11):2027-33. PubMed ID: 26169757
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. LPA1 receptor-mediated thromboxane A2 release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.
    Dancs PT, Ruisanchez É, Balogh A, Panta CR, Miklós Z, Nüsing RM, Aoki J, Chun J, Offermanns S, Tigyi G, Benyó Z.
    FASEB J; 2017 Apr 19; 31(4):1547-1555. PubMed ID: 28069828
    [Abstract] [Full Text] [Related]

  • 11. Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury.
    Santos-Nogueira E, López-Serrano C, Hernández J, Lago N, Astudillo AM, Balsinde J, Estivill-Torrús G, de Fonseca FR, Chun J, López-Vales R.
    J Neurosci; 2015 Jul 15; 35(28):10224-35. PubMed ID: 26180199
    [Abstract] [Full Text] [Related]

  • 12. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.
    Ueda H, Neyama H, Matsushita Y.
    Cells; 2020 Aug 16; 9(8):. PubMed ID: 32824296
    [Abstract] [Full Text] [Related]

  • 13. A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
    Taleb SJ, Wei J, Mialki RK, Dong S, Li Y, Zhao J, Zhao Y.
    J Cell Biochem; 2021 Aug 16; 122(8):827-834. PubMed ID: 33847006
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization.
    Funke M, Knudsen L, Lagares D, Ebener S, Probst CK, Fontaine BA, Franklin A, Kellner M, Kühnel M, Matthieu S, Grothausmann R, Chun J, Roberts JD, Ochs M, Tager AM.
    Am J Respir Cell Mol Biol; 2016 Jul 16; 55(1):105-16. PubMed ID: 27082727
    [Abstract] [Full Text] [Related]

  • 15. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
    Zhao J, Wei J, Weathington N, Jacko AM, Huang H, Tsung A, Zhao Y.
    Transl Res; 2015 Jul 16; 166(1):80-8. PubMed ID: 25701366
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lysophosphatidic acid induces vasodilation mediated by LPA1 receptors, phospholipase C, and endothelial nitric oxide synthase.
    Ruisanchez É, Dancs P, Kerék M, Németh T, Faragó B, Balogh A, Patil R, Jennings BL, Liliom K, Malik KU, Smrcka AV, Tigyi G, Benyó Z.
    FASEB J; 2014 Feb 16; 28(2):880-90. PubMed ID: 24249637
    [Abstract] [Full Text] [Related]

  • 20. LPA receptor signaling as a therapeutic target for radical treatment of neuropathic pain and fibromyalgia.
    Ueda H.
    Pain Manag; 2020 Jan 16; 10(1):43-53. PubMed ID: 31852400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.